Literature DB >> 18723128

Aberrant T cell ERK pathway signaling and chromatin structure in lupus.

Gabriela Gorelik1, Bruce Richardson.   

Abstract

Human systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibodies to nuclear components with subsequent immune complex formation and deposition in multiple organs. A combination of genetic and environmental factors is required for disease development, but how the environment interacts with the immune system in genetically predisposed hosts to cause lupus is unclear. Recent evidence suggests that environmental agents may alter T cell chromatin structure and gene expression through effects on DNA methylation, a repressive epigenetic mechanism promoting chromatin inactivation, to cause lupus in people with the appropriate genetic background. DNA methylation is regulated by ERK pathway signaling, and abnormalities in ERK pathway signaling may contribute to immune dysfunction in lupus through epigenetic effects on gene expression. This article reviews current evidence for epigenetic abnormalities, and in particular DNA demethylation, in the pathogenesis of idiopathic and some forms of drug-induced lupus, and how impaired ERK pathway signaling may contribute to the development of human lupus through effects on T cell DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723128      PMCID: PMC2642928          DOI: 10.1016/j.autrev.2008.07.043

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  19 in total

Review 1.  Abnormal T cell signal transduction in systemic lupus erythematosus.

Authors:  Gary M Kammer; Andras Perl; Bruce C Richardson; George C Tsokos
Journal:  Arthritis Rheum       Date:  2002-05

Review 2.  Drug-induced lupus.

Authors:  R L Yung; B C Richardson
Journal:  Rheum Dis Clin North Am       Date:  1994-02       Impact factor: 2.670

3.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  B Richardson; L Scheinbart; J Strahler; L Gross; S Hanash; M Johnson
Journal:  Arthritis Rheum       Date:  1990-11

4.  Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients.

Authors:  C Deng; M J Kaplan; J Yang; D Ray; Z Zhang; W J McCune; S M Hanash; B C Richardson
Journal:  Arthritis Rheum       Date:  2001-02

5.  Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus.

Authors:  B C Richardson; J R Strahler; T S Pivirotto; J Quddus; G E Bayliss; L A Gross; K S O'Rourke; D Powers; S M Hanash; M A Johnson
Journal:  Arthritis Rheum       Date:  1992-06

6.  Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus.

Authors:  Gabriela Gorelik; Jing Yuan Fang; Ailing Wu; Amr H Sawalha; Bruce Richardson
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

7.  Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.

Authors:  Kurt Oelke; Qianjin Lu; Derek Richardson; Ailing Wu; Chun Deng; Samir Hanash; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2004-06

8.  Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus.

Authors:  Qianjin Lu; Mariana Kaplan; Donna Ray; Doreen Ray; Sima Zacharek; David Gutsch; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2002-05

9.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

10.  Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.

Authors:  Chun Deng; Qianjin Lu; Zhiyong Zhang; Tharaknath Rao; John Attwood; Raymond Yung; Bruce Richardson
Journal:  Arthritis Rheum       Date:  2003-03
View more
  15 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 2.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

4.  Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus.

Authors:  Katsue Sunahori; Yuang-Taung Juang; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

5.  DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells.

Authors:  F-C Chou; C-C Kuo; H-Y Chen; H-H Chen; H-K Sytwu
Journal:  Genes Immun       Date:  2016-02-18       Impact factor: 2.676

Review 6.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

7.  Changed genome heterochromatinization upon prolonged activation of the Raf/ERK signaling pathway.

Authors:  Catherine Martin; Songbi Chen; Daniela Heilos; Guido Sauer; Jessica Hunt; Alexander George Shaw; Paul Francis George Sims; Dean Andrew Jackson; Josip Lovrić
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients.

Authors:  Katsue Sunahori; Kamalpreet Nagpal; Christian M Hedrich; Masayuki Mizui; Lisa M Fitzgerald; George C Tsokos
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

Review 9.  Epigenetic therapeutics in autoimmune disease.

Authors:  Moshe Szyf
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

10.  Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; Takayuki Katsuyama; Sarah Solomon; Eri Katsuyama; Vasileios C Kyttaris; Vaishali R Moulton; George C Tsokos
Journal:  J Immunol       Date:  2018-03-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.